Rep. Mary E. Miller

This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.) The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions. In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers. The bill nullifies the January 2023 changes and prohibits any similar changes in the future.

Maddy summaryThis bill prohibits federal funding to Planned Parenthood Federation of America and its affiliates for one year unless they certify they won't perform or fund abortions (with exceptions for rape/incest or life-threatening conditions). It redirects $235 million in existing funding to community health centers for women's health services like contraception, cancer screenings, and prenatal care. The bill explicitly states that redirected funds will continue to support all women's health services previously provided by Planned Parenthood. It also requires repayment of funds if Planned Parenthood violates the certification, and clarifies that overall federal funding for women's health services remains unchanged.

Protecting Life from Chemical Abortions Act This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.) The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions. In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers. The bill nullifies the January 2023 changes and prohibits the FDA from (1) exercising any enforcement discretion with respect to program requirements, or (2) reducing program protections until every state submits certain data regarding abortions to the Centers for Disease Control and Prevention. The bill also generally prohibits the declaration of a public health emergency with respect to abortions.

Maddy summaryHR 553, the Workplace Choice and Flexibility for Individuals with Disabilities Act, amends the Rehabilitation Act of 1973 to clarify what counts as "competitive integrated employment" for people with disabilities. It updates the definition to explicitly include social interactions with colleagues and customers in regular workplace settings (not just isolated work units) and specifies that jobs paid through federal or state government contracts prioritizing disability employment support - such as those awarded to contractors or subcontractors meeting certain criteria - qualify as competitive. This change ensures state vocational rehabilitation programs can count these jobs as legitimate employment outcomes, aligning with Congressional intent that such roles be considered part of the broader labor market. The bill directly affects state agencies managing vocational rehabilitation services and government contractors providing disability-focused employment support.

No Taxpayer Funding for the Chinese Communist Party Act of 2023 This bill requires the Department of Justice to report to Congress on the extent to which China has benefited from U.S. taxpayer-funded research. The report shall also contain information including (1) a list of U.S. government-funded entities that have hired Chinese nationals; and (2) a list of U.S. government programs in the science, technology, engineering, and math fields that have cooperated or affiliated with research institutions in China or Chinese Communist Party entities.

No Tax Dollars for the United Nation's Immigration Invasion Act This bill prohibits the federal government from making contributions to the United Nations (U.N.) International Organization for Migration, the U.N. High Commissioner for Refugees, or the U.N. Relief and Works Agency for Palestine Refugees in the Near East. The bill also requires the Government Accountability Office to report to Congress on federal funds provided to these U.N. agencies, including the amounts provided during FY2021 and FY2022 and any restrictions attached to such funding.

Maddy summaryThe Educational Choice for Children Act creates tax credits for individuals and corporations that contribute to scholarship granting organizations providing education scholarships. Individuals can claim a credit up to $5,000 or 10% of their income, while corporations can claim up to 5% of taxable income. The scholarships are available to students from households with income up to 300% of the area median income, and can be used for private school tuition, tutoring, and other educational expenses at elementary and secondary schools. The bill includes strict requirements for scholarship organizations to verify income, conduct audits, and prevent misuse of funds, while also prohibiting government control over these organizations and protecting private and religious schools from discrimination in the program. It establishes a $10 billion annual cap on the total tax credits available.

One Citizen One Vote Act This bill prohibits the Election Assistance Commission from making payments to any state or jurisdiction unless the state or jurisdiction certifies that it meets certain election standards. Specifically, the state or jurisdiction must certify that it requires a photo identification for voting, restricts the delivery of ballots by third parties (i.e., prohibits ballot harvesting), prohibits the use of a drop box for collecting a voted ballot unless it is located at the office of an election official, does not deliver an absentee or other mail-in ballot to any individual who does not request the delivery of such a ballot, and does not allow noncitizens to vote in any election.

Maddy summaryThis bill expands foreign investment review to cover U.S. agriculture by requiring transactions involving foreign control of agricultural businesses to undergo scrutiny by the Committee on Foreign Investment (CFIUS). It classifies agricultural supply chains as both critical infrastructure and critical technologies, directly affecting foreign entities seeking to acquire or influence U.S. farms, food production, and supply chains. The bill mandates annual reports from the Secretary of Agriculture and the Government Accountability Office on foreign investments in agriculture, including risks to food security and intellectual property. These provisions aim to mitigate potential threats to U.S. food supply chains from foreign adversaries through enhanced oversight.

Maddy summaryThis bill prohibits all federal funding from being provided to EcoHealth Alliance, Inc. and its directly controlled subsidiaries, related organizations, or subgranted entities. It directly affects EcoHealth Alliance by cutting its access to federal grants, contracts, or other funding sources. The bill also requires the Government Accountability Office (GAO) to study and report on all federal funds provided to EcoHealth Alliance - whether intentionally or accidentally - to Chinese entities like the Wuhan Institute of Virology or the Chinese Communist Party, during the prior decade. The report must detail these funds and include any related agreements involving foreign entities. The bill focuses on restricting funding flows and requiring transparency, not on policy outcomes or advocacy.